Journalist Alex Berenson said Meta CEO Mark Zuckerberg’s admission that his company, Facebook, was pressured by the Biden-Harris administration to censor Americans, particularly regarding COVID ...

Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Cutting out middleman and selling drugs straight to patients. The company launched ...

Pfizer and Valneva may have about two more years to wait before they make the first approval filing to the FDA for a Lyme disease vaccine, but that hasn’t stopped the companies collecting more ...

Through its Ignite program, Pfizer partners with biotechs to help them advance new drugs from preclinical development all the way to market.Ignite mainly focuses on oncology, inflammation and ...

NEW YORK, Sept 14 (Reuters) - Pfizer (PFE.N), opens new tab is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi ...

Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield-- the highest among major drug manufacturers and one of the ...

The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday, a week after giving Pfizer and Moderna the OK on their shots, though all drugmakers say their shots will be ...

Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Using telehealth to sell drugs straight to patients. The company launched a website ...

To start, according to Pfizer’s launch announcement Tuesday, the platform’s services will focus on providing access to treatments for common conditions like migraine, COVID-19 and the flu as ...

Aug 27 (Reuters) - Pfizer Inc (PFE.N), opens new tab is launching a new website to promote and improve access to its health care offerings for migraine and respiratory illnesses. The drugmaker ...

A month has gone by since the last earnings report for Pfizer (PFE). Shares have lost about 5.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

To counter new forms of the virus, FDA approved updated vaccines from both Pfizer and Moderna last week. These new vaccines specifically target the KP.2 strain, a descendant of the Omicron variant.